Fig. 4

Open Innovation Model emphasizes integrative science through collaboration, strategic alliance, open-sharing of internal R&D and external R&D, using existing knowledge (data), taking up other multifaceted approaches and accruing benefits from advances on different fronts of new drug discovery and development process to create internal and external knowledge and resources to create value and to capture a piece of that value. Because the open innovation model shares the innovation cost and minimizes innovation risk, it has the potential to self-sustain itself creating new technology and products for new markets or displacing existing products in the current markets as well as potential out licensing opportunities for the products and technology developed during this process